CH-19 Sweet is a newly found chili pepper breed bearing much less pungent fruits. Because CH-19 Sweet fruits were found to contain three analogs (capsinoids) of capsaicin, a major component of pungency of hot peppers (the analogs are capsiate or CST, dihydrocapsiate or DCT, and nordihydrocapsiate or NDCT), we assessed in this study the bio-potencies of these three capsinoids by comparing them with capsaicin. The three capsinoids bound to transient potential vanilloid 1 (TRPV1) receptors expressed in cultured cells and activated Ca 2þ influx in a concentration-dependent manner with similar magnitudes. In contrast to capsaicin, capsinoids at the same concentration induced virtually no nociceptive responses when applied to the eyes or the oral cavities of mice. Intravenous administration of capsaicin or 20-fold increased doses of each capsinoid to rats induced significant increases in plasma catecholamine levels. Orally administered, each capsinoid enhanced oxygen consumption in mice. Based on the present results, capsaicin and these three capsinoids should have similar bio-potency, though capsinoids do not generate pungency or sensory irritation.
Key words: capsiate; transient potential vanilloid 1 (TRPV1); sympathetic nervous system; energy metabolism; capsinoid Capsaicin (CAP, Fig. 1 ) is a pungent substance of capsicum fruits known to have diverse biological activities. It is thought to prevent positive energy balance as well as obesity 1, 2) because it has been reported to increase catecholamine secretion, 3, 4) energy expenditure, 1) and body fat loss after long-term treatment in experimental animals. 5) Breakfast with hot peppers was reported to increase diet-induced energy expenditure in Japanese males. 6) The strong pungency of hot peppers, but, restricts common long-term usage. Thus, in this context, reports that CH-19 Sweet, a non-pungent cultivar of red pepper, has biological activities similar to those of red pepper despite its non-pungency [7] [8] [9] are noteworthy. Research with CH-19 Sweet or its extract has also described enhanced energy metabolism and body temperature in studies with humans. [7] [8] [9] As illustrated in Fig. 1 , CAP consists of a vanillyl moiety and a fatty acid chain that are conjugated with an amide bond. CH-19 Sweet fruits contain only a very small amount of CAP 10) but abundant capsiate (CST), in which the two components are conjugated with an ester bond ( Fig. 1) . CST has been found to activate the capsaicin receptor, transient receptor potential vanilloid subtype 1 (TRPV1). 11) This induces a rapid increase in the intracellular free Ca 2þ concentration and activates peripheral neurons. 12) Furthermore, CST administration to mice was also found to increase energy consumption and body fat loss. 1) We isolated two other minor compounds in addition to CST from the extract of CH-19 Sweet fruits, dihydrocapsiate (DCT) and nordihydrocapsiate (NDCT), with slight variations in the fatty acid chain (Fig. 1) . 13, 14) These compounds are generically called capsinoids. 14) Because the fatty acid chains of capsinoids generally have key roles in their affinity to TRPV1, 15) their biopotencies are elusive.
In the present study, we found that the three analogs activated the capsaicin receptor (TRPV1 receptor) in TRPV1-expressing Human Embryonic Kidney 293 (HEK293) cells, although they induced virtually no nociceptive responses in mice, unlike capsaicin. Intravenous administration of any of these compounds to rats elevated circulating catecholamine levels, and oral administration resulted in elevated energy consumption at similar magnitudes.
Materials and Methods
Materials. CAP was purchased from Sigma-Aldrich Japan (Tokyo). CST, DCT, and NDCT were synthesized enzymatically, as described previously.
16) The purities of all compounds were confirmed to be over 98% by reversed-phase high performance liquid chromatography (HPLC). All other chemicals were guaranteed reagent-grade.
Measurement of intracellular Ca
2þ concentrations in TRPV1-expressing HEK293 cells. Intracellular Ca 2þ concentrations after capsaicin or one of the three capsinoid treatments were measured in HEK293 cells that stably expressed TRPV1 (named HEK293VR11 cells), essentially following a method described previously. 15 , and 0.1% bovine serum albumin) at pH 7.4. Time-dependent changes in fluorescence (excitation wavelength, 340 and 380 nm; emission wavelength, 500 nm) were recorded with a CAF-110 fluorospectrophotometer (JASCO, Tokyo). Each datum was expressed as a percentage of the response to 10 mM CAP in each experiment. Curve fitting and parameter estimation were carried out using the Prism4 program (GraphPad Software, La Jolla, CA).
The irritancy assay. Male ddY mice (5-6 weeks old, Japan SLC, Shizuoka, Japan) were housed in a controlled-lighting environment (lights on from 0700 to 1900 h) with food and water available ad libitum. The animals were placed individually in a transparent cage (19:5 cm Â 12:0 cm Â 12:0 cm) that also served as an observation chamber. After 1 h for adaptation, each mouse was taken out from its cage temporarily and administered the test reagent, as described below. Each animal was used in only one test. All the animal experiments were approved by the Animal Committee of Ajinomoto Co., Inc. (Tokyo), and the animals received care under the guidelines for care and use of laboratory-animals of this committee.
Taste aversion assay was performed by the method described by Spector et al., 17) with necessary modifications. Each animal was placed in a different chamber bedded with chips from the housing cage. Twenty ml of one of three capsinoids (0.5 mM in distilled water containing 5% dimethyl sulfoxide, DMSO) or CAP (0.5 mM) was placed in the oral cavity using an Eppendorf pipette. An aversive response (gaping; an activity intended to expel the oral content) was observed during the 3 min following administration.
An eye irritancy assay was carried out by administering 2 ml of one of the capsinoids or CAP (0.5 mM in saline containing 5% DMSO) to the eye using an Eppendorf pipette, as described previously.
18) The number of wiping reactions was counted for 2 min after administration.
Plasma catecholamine levels. Male Sprague-Dawley rats (250-270 g, Charles River Laboratories Japan, Yokohama, Japan) were anesthetized with urethane (1.2 g/kg of BW). The rectal temperature was maintained at 37 C by placing the animals on a heating pad. Polyethylene tubes filled with heparinized saline were placed in bilateral femoral veins. After a 30-min resting period, 1 ml of blood was sampled from the left femoral vein for 3 min to obtain basal catecholamine levels. The same amount of artificial plasma (Salinhes, Kyorin Pharmaceutical Lt., Tokyo) was replenished from the left femoral vein. After another 30 min, a capsaicin solution (100 mg/kg of BW) or one of the three capsinoid solutions (2000 mg/kg of BW) was administered to the right femoral vein for 1 min, and the 3-min period of blood sampling was started upon injection. Before blood collection, 10 ml of 10% sodium pyrosulfite and 10 ml of 10% ethylenediaminetetraacetic acid (EDTA) were added to the collection tubes. After centrifugation of the blood, 300 ml of plasma was kept at À20 C until assay. 3,4-Dihydroxybenzylamine was added to the plasma as an internal standard. Catecholamines (adrenaline and noradrenaline) were adsorbed onto activated alumina at pH 8.6, washed with methanol and water, and then eluted with 0.4 N perchloric acid. The amount of catecholamines was analyzed by HPLC with an electrochemical detector, as follows: Separation was done with a reversed-phase silica gel column (Cosmosil 5C18-AR-II, '4:6 Â 250 mm; Nacalai Tesque, Kyoto, Japan) with a guard column (Cosmosil Guard Column 5C18-AR-II, '4:6 Â 10 mm) maintained at 30 C, and detection was done using an electrochemical detector with the potential value set at 300 mV (CoulArray Multi-Channel ECD System, ESA Laboratories, Chelmsford, MA). Methanol buffer (8:92, v/v) composed of 50 mM potassium phosphate buffer (pH 3.4). 10 mM EDTA-2Na, and 100 mg/l sodium 1-octanesulfonate was used as the mobile phase with a flow rate of 1.0 ml/min.
Respiratory gas analysis. Five-week-old male Std ddY mice (Japan SLC) were housed in standard cages (33 Â 23 Â 12 cm 3 ) under controlled temperature (24 C AE 0:5), humidity (50%), and lighting (lights on from 0700 to 1900 h). Each animal was anesthetized with urethane (1.2 g/kg of BW) and placed in a metabolic chamber after oral administration of vehicle or one of the three capsinoids (10 mg/kg of BW).
Utilizing a respiratory gas analysis system consisting of an acrylic metabolic chamber, gas analyzers, and a switching system (ARCO2000-RAT/ANI System, Arco System, Chiba, Japan), sampled gas from each metabolic chamber was measured as described previously.
1) Briefly, room air was constantly pumped through the chamber, and expired air was dried in a thin cotton column and then introduced into a gas analyzer. Oxygen consumption was calculated as the area under the curve (AUC) from 3 to 80 min after reagent administration.
Results
The three capsinoids activated TRPV1 TRPV1 is activated by CAP and is also known as the capsaicin receptor. It is a non-selective cation channel expressed on the plasma membrane and is found in heatsensitive neurons. 19) We examined whether the capsi- noids would bind to and consequently activate TRPV1 expressed in HEK293 cells (HEK293VR11). Figure 2 shows the concentration-response curve for CAP and the three capsinoids (CST, DCT, and NDCT). CAP increased the intracellular Ca 2þ concentration-dependently in HEK293VR11 cells, with an EC 50 value of 0.049 mM. All three capsinoids equally increased the intracellular Ca 2þ concentration. The EC 50 values for CST, DCT, and NDCT were 0.58 mM, 0.67 mM, and 0.56 mM respectively, and the maximum response to the three capsinoids was 90% of that of CAP. Thus the potency of the capsinoids was approximately 1/10 that of CAP. These calcium responses by capsinoids (10 mM) were not observed in the parent HEK293 cell (data not shown).
Irritancy-related effects of capsinoids on the oral cavity and the eye
In humans, the lesser pungency of the capsinoids is apparent upon eating CH-19 Sweet fruits. To confirm this in rodents, CAP and capsinoids CST, DCT, and NDCT were applied to the oral cavity or to the eyes of mice. At a dose (0.5 mM) of capsaicin that induced almost relentless gaping episodes (142:02 AE 7:11 s/ 3 min), the capsinoids induced many fewer gaping episodes that were not significantly different from the vehicle control.
The capsinoids, moreover, did not induce an eye irritation response. The somata of sensory neurons at the eye surface are known to be located in the trigeminal ganglion. As in the gaping test, at a dose (0.5 mM) of capsaicin, which induced repeated and almost constant eye wiping episodes (20:33 AE 3:17 times/2 min), the capsinoids induced many fewer eye wiping episodes as above not significantly different from the vehicle control (Table 1) .
Plasma catecholamine concentrations after intravenous administration of capsaicin and the capsinoids
We have carried out experiments to measure plasma catecholamine from adrenal venous blood, particularly to assess adrenaline secretion from the adrenal medulla. 3, 20) In this study, blood was sampled from the femoral veins of rats to evaluate the levels of circulating noradrenaline, including that released from the peripheral nerve endings. Since the experimental procedure itself sometimes considerably affects plasma catecholamine levels, 21) we set up a procedure in which there were no significantly different levels of catecholamines between samples with and without vehicle administration (data not shown). By preliminary experiments, we found the following: the peak in plasma catecholamine (adrenaline and noradrenaline) levels was attained within 3 min after CAP administration (data not shown), and significant elevations in catecholamine levels were induced by 1-200 mg/kg of BW of CAP and 1,000-5,000 mg/kg of BW of capsinoids (data not shown). Accordingly, the testing doses in this study were set at 100 mg/kg of BW for CAP and 2,000 mg/kg of BW for the capsinoids.
At the above doses, no significant differences were observed either in adrenaline (Fig. 3A) or in noradrena-
%Activity at 10 µM capsaicin Fig. 2 . TRPV1 Activation by CAP and Capsinoids (CST, DCT, and NDCT). TRPV1 activation was assessed by the change in Ca 2þ -induced fluorescence of HEK293VR11 cells loaded with fura-2 AM. Data are expressed as percentages of the response to CAP at 10 mM. Each point represents the mean value AE SEM for three to four experiments. line (Fig. 3B ) levels less than 3 min after intravenous administration of capsaicin or one of the three capsinoids.
Oxygen consumption after administration of the capsinoids
Oxygen consumption was measured by respiratory gas analysis for the mice. Increased oxygen consumption was observed immediately after oral administration of each of the capsinoids, and this lasted for the 80 min of the observation period. Temporary increases caused by vehicle administration returned to the basal level by 30 min. AUC for all capsinoid groups were significantly greater than those of the vehicle group (Fig. 4) . None of the capsinoids changed the respiratory quotient significantly (data not shown).
Discussion
The three capsinoids (CST, DCT, and NDCT) contained in CH-19 Sweet fruits were found to bind and activate TRPV1 similarly to capsaicin, though the potency as assessed by increased intracellular Ca 2þ concentration was approximately 1/10 of that of capsaicin. The EC 50 value for CST was 0.58 mM, which is consistent with our previous report.
15 ) The EC 50 values and maximum responses for DCT and NDCT were similar to that for CST. Thus TRPV1 activation potency was virtually equal among the three capsinoids.
The pungency of CAP restricts daily ingestion of hot peppers to less than an amount effective for enhancing the energy expenditure of the ingesting person. Pungency or a burning sensation is believed to be the outcome of activation of TRPV1 expressed on heatsensitive neurons. 22) Because the three capsinoids were found to be agonists of TRPV1 in this study, we examined whether an interaction between the capsinoids and the TRPV1 receptor would lead to a painful sensation in vivo. Neither the oral nor the eye-irritancy assay demonstrated nociceptive responses in rats at a dose CAP administration led to intense nociceptive behavior. Iida et al. reported 11) that CST and olvanil (a non-pungent CAP analog) activated TRPV1 on cultured cells and generated irritancy in mice receiving them subcutaneously, but not in mice receiving them orally or around the eye area. It was proposed that the accessibility of the compound to sensory neurons plays a key part in the expression of nociceptive behavior, and it was stated that this accessibility to sensory neurons was likely to depend on the physical properties of CST and olvanil, including lipophilicity and conspicuously low stability in an aqueous environment.
11) These findings and remarks are consistent with the present data demonstrating the inability of the three capsinoids to induce nociceptive behavior because DCT and NDCT share similar physical properties with CST. 13, 14) Therefore, the absence of nociceptive behaviors from this study might be due to lipophilicity or hydrolysis of the capsinoids before they reach the nerve endings that express TRPV1, which innervate the oral cavity and the eye surface, but further studies are needed to confirm this, particularly studies employing higher doses of the capsinoids.
CAP, either orally ingested or intravenously injected, has been found to induce adrenaline secretion from the adrenal medulla through activation of the sympathetic nervous system, 23) leading to increased energy metabolism and decreased adipose tissue volume in high-fat fed rats. 5) These reactions are believed to start when CAP activates TRPV1 expressed on the peripheral nerve endings.
2) We tried to confirm the catecholamine secretory activity of intravenously administered capsinoids. As expected, intravenous injections of CST and of DCT significantly elevated both the adrenaline and the noradrenaline level, as well as the NDCT and the noradrenaline level. Intravenous injection of olvanil and of CST has been reported to induce adrenaline secretion in rats 2, 24) despite a lack of irritancy to the eye.
11)
Therefore, capsinoids can access TRPV1 expressed on peripheral nerve endings via the vessels before degradation. Approximately 20-fold increases in dose were required for the capsinoids to induce elevations similar to that observed with CAP. This was probably due either to instability in the aqueous environment or to the lesser binding affinity of the capsinoids to TRPV1, as in this study by the intracellular Ca 2þ increase. The two catecholamines ratios after intravenous treatment of each of the capsinoids were different from those of CAP. The capsinoids brought about a noradrenaline-dominant secretory pattern, while CAP did the same for an adrenaline-dominant one. This suggests that there are differences in sympathetic drives stimulated by CAP and by capsinoids. It has been that the regulation of sympathetic outflow is highly controlled 25) and depends on various stimulants, including cold and glucoprivation. 26) In a series of studies to evaluate capsinoid safety, Bernard et al. 27 ) that capsinoids were not transferred to the circulation after oral intake in humans due to breakdown of the ester bond by hydrolysis before digestive absorption. But, Hachiya et al. 28) reported that oral ingestion of capsicum-containing capsinoids without capsaicinoids (capsaicin or capsaicin analogs with an amide bond) activated the sympathetic nervous system in humans but did not change the blood pressure, whereas capsicum-containing capsaicinoids did. This apparent contradiction raises the question why capsinoids activate the sympathetic nervous system even though they do not enter the bloodstream in an intact form. The discrepant findings might be reconciled by the fact that TRPV1 is also expressed on peripheral nerve endings distributed in the gastric mucous membrane. 29) The orally ingested capsinoids in the study of Hachiya et al. 28) bound to TRPV1 expressed on the gastric surface and triggered it to activate the sympathetic nervous system.
Since it was reported that orally administration of CAP and of CST enhanced oxygen consumption in mice at similar magnitudes, 1) we evaluated the bio-potency of three capsinoids orally administrated in mice with by calorimetry. The orally ingested capsinoids were to enhance energy consumption almost equally via detection of elevated oxygen consumption after treatment. Although the adrenaline secretion induced by intravenous NDCT was less than that induced by the other two capsinoids, the ability of oral NDCT to enhance energy metabolism was comparable. Thus, efferent projections can be differentiated according to the origin and/or intensity of afferent stimuli.
In this study, we found that DCT and NDCT had much less pungency than CAP, are agonists of TRPV1, and enhance energy consumption through activation of the sympathetic nervous system as well as those of CST. These results suggest DCT and NDCT contribute to the physiological functions of CH-19 Sweet fruits, including enhancing energy consumption.
